Track the KERYX BIOPHARMACEUTICALS INC share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). The latest transaction was filed on 10 February 2016 (Cession). Among the most active insiders: Adams Brian. Every trade is accessible without an account.
10
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
6 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Keryx Biopharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for renal diseases. It is listed on NASDAQ under the ticker KERX.